The Epstein-Barr virus seems to affect gene expression and cell signalling in a way that causes the autoimmune condition multiple sclerosis ...
Zacks Investment Research on MSN
ATRA stock shoots up 82% in a month: Here's what you should know
Atara Biotherapeutics ATRA shares have rallied 82.4% in a month, primarily driven by a positive regulatory update earlier in ...
Not all cancers respond to the same treatments or have the same genetic origins. Epstein–Barr virus (EBV), a common and ...
Feb 25 (Reuters) - (Health Rounds is published on Tuesdays and Thursdays. Think your friend or colleague should know about us? Forward this newsletter to them. They can also subscribe here.) ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...
Scientists from the US have developed antibodies that target Epstein-Barr virus (EBV), a common virus linked to several ...
Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results